Urology Devices Market – By Product Type, By Application, By End Use – Global Forecast, 2025 – 2034

Urology Devices Market Size

The global urology devices market was estimated at USD 36.8 billion in 2024. The market is expected to grow from USD 39.3 billion in 2025 to USD 73.5 billion in 2034, growing at a CAGR of 7.2%. This high growth is attributed to several factors, including the rising prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia (BPH), and kidney stones.

Increasing demand for minimally invasive procedures and home-based urological care is also contributing to market expansion. Furthermore, advancements in urology-specific technologies and smart diagnostic tools are positively influencing the adoption of innovative urology devices.
 

A urology device is a medical instrument used for diagnosing, treating, or managing conditions related to the urinary tract and male reproductive system. These include devices for procedures such as stone removal, prostate surgery, urinary incontinence management, and bladder monitoring. Major players in the industry include Boston Scientific Corporation, Olympus Corporation, Cook Medical, Dornier MedTech, and Teleflex. Typically, biologics or large-volume injectables such as monoclonal antibodies cannot be administered using standard syringes or auto-injectors.
 

The market grew from USD 30.3 billion in 2021 to USD 34.4 billion in 2023, registering a CAGR of 7.2% during this period. This growth has been primarily driven by an increasing global prevalence of urological disorders, a rising geriatric population, and technological innovations across diagnostic and surgical urology platforms. The growing awareness regarding the minimally invasive procedures and the rising demand for home-based urological care have further contributed to the market expansion.
 

One of the critical market shifts is the rising adoption of minimally invasive and robotic-assisted urological surgeries, particularly for conditions such as benign prostatic hyperplasia (BHP), urolithiasis, and prostate cancer. Robotic systems have transformed the landscape of urological devices by enhancing precision, reducing recovery time, and improving patient outcomes. Systems such as Medtronic’s Hugo RAS have seen widespread adoption globally in a short time, especially in prostatectomy procedures.
 

Additionally, the U.S. FDA has played an important role in supporting this trend by approving next-generation urology devices that improve the efficiency of procedures and also patient comfort. For example, in 2022, the UroLift 2System by Teleflex received FDA clearance featuring a small delivery profile for improved navigation in the prostatic urethra.
 

Urology devices are specialized medical tools used to diagnose and treat disorders of the urinary tract and male reproductive system. These devices assist in managing conditions such as kidney stones, urinary incontinence, prostate enlargement, and bladder or prostate cancer. It is commonly used in hospitals, surgical centers, and urology clinics.
 

Urology Devices Market Trends

The global medical market experiences dynamic transformation driven by both macro and micro-level trends. On the macro level, the rising global burden of urological disorders such as kidney disease, bladder cancer, and other disorders is accelerating the demand for innovative, minimally invasive diagnostic, and therapeutic devices.
 

• According to the World Health Organization (WHO), in 2025, kidney diseases rank among the top ten causes of death in multiple regions worldwide. This growing clinical burden has reinforced the need for timely diagnosis and effective treatment using advanced devices such as ureteroscopes, cystoscopes, and ureteral stents.
• From a regulatory and care delivery standpoint, there is a broader healthcare system shift towards ambulatory, outpatient, and home-based care, leading to increased adoption of compact, disposable, and patient-friendly urology devices.
   
• At the micro trend level, rapid product innovation and digitization are escalating the market. Manufacturers are introducing next-generation devices that improve safety and reduce the risk of infection. For example, Boston Scientific’s LithoVue Elite, launched in 2023, is a single-use digital flexible ureteroscope that features real-time intrarenal pressure monitoring and reduces the risk of renal damage.
   
• In addition, robotic-assisted surgeries are gaining traction, particularly in prostatectomy and nephrectomy. Systems such as Intuitive Surgical’s Da Vinci have expanded access to precision urological interventions across both developed and emerging markets. These robotic platforms offer enhanced dexterity, 3D visualization, and smaller incisions, improving patient outcomes.
   
• Moreover, the emerging technologies in laser lithotripsy, AI, and disposable optics are enabling more accurate stone fragmentation, real-time diagnostics, and sterile intervention.
   

Urology Devices Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

The global market was valued at USD 30.3 billion in 2021. The market size reached USD 34.4 billion in 2023, from USD 32.3 billion in 2022.
 

Based on the product type, the market is segmented into product and accessories. The accessories is further subdivided into endoscopes, laser and lithotripsy devices, dialysis devices, and other products. The product segment accounted for 30.2% of the market in 2024 due to their high imaging precision, customizable configurations, and ability to support complex diagnostic and therapeutic procedures. The segment is expected to exceed USD 22.8 billion by 2034, growing at a CAGR of 7.5% during the forecast period. On the other hand, a product segment type including the laser and lithotripsy devices segment is expected to grow with a CAGR of 8%. The growth of this segment can be attributed to their cost-effectiveness, ease of use, and increasing preference for minimally invasive stone management solutions that offer faster recovery and reduced procedural complications.
 

• The endoscope sub-segment within the product segment holds the dominant share in the urology devices market, primarily due to its critical role in both diagnostic and therapeutic urological procedures. These instruments enable direct visualization and intervention within the urinary tract, including the urethra, bladder, ureters, and kidneys, making them important in treating conditions such as kidney stones, bladder tumors, among others.
   
• Common types include cystoscopes and ureteroscopes, which are widely used in procedures such as transurethral resection, ureteroscopy.
   
•  This segment is escalating due to an increase in demand for minimally invasive and magnetic-guided procedures, which offer faster recovery and shorter hospital stays. The rising prevalence of urological disorders, combined with improvements in endoscopic visualization, has positioned endoscopes as the cornerstone in modern practice.
   

• Technological advancements such as high-definition imaging, digital integration, and single-use scopes have further propelled the segment’s growth. Products such as Olympus’s URF-V3 and Karl Storz’s Flex-Xc are prime examples of how innovation in endoscopic technology improves procedural efficiency and patient safety. This shift towards digital and disposable endoscopes, which was valued at USD 1.9 billion in 2024, also addresses infection control concerns.
   
• In healthcare, endoscopes are gaining prominence for their ability to support personalized and cost-effective treatment. Enhanced ergonomics, lightweight design, and compatibility with digital platforms are making them more accessible in both high-volume surgical centers and outpatient settings.
   

Based on the application, the urology devices market is segmented into urolithiasis, urethral malignancies, bladder disorders, kidney diseases, erectile dysfunction, and other applications. The urolithiasis segment accounted for the highest market share of 31.2% in 2024, owing to the rising incidence of kidney stones, increasing adoption of minimally invasive stone removal techniques, and growing preference for outpatient lithotripsy procedures.
 

• The urolithiasis segment accounted for the highest market share, supported by the increasing preference for minimally invasive procedures and advancements. According to a study published in 2022 by PubMed, more than 115 million new cases of urolithiasis were recorded globally, with nearly 13,279 deaths. The widespread prevalence and growing recurrence rates have significantly elevated the demand for efficient diagnostic and therapeutic urology devices.
   
• The dominance of urolithiasis is due to its chronic and recurrent nature, which often requires repeat diagnostics, follow-up imaging, and secondary interventions, sustaining long-term demand for ureteroscopes and accessory retrieval tools. This high recurrence rate drives the usage of advanced ureteroscopes, stone baskets, and high-powered laser systems in both hospital and ambulatory care settings.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on the end use, the urology devices market is segmented into hospitals and clinics, dialysis centers, and home care settings. The hospitals and clinics segment accounted for 56.2% market share in 2024, driven by the high volume of urological procedures performed in clinical settings, availability of advanced infrastructure, and growing preference for specialized care and minimally invasive treatments.
 

• These settings serve as the primary point of care for complex surgeries and in the management of urologic malignancies. The comprehensive diagnostic and surgical capabilities make them the preferred choice for both emergency and elective urological care.
   
• Hospitals and clinics dominate due to their ability to manage high patient loads, perform advanced minimally invasive surgeries, and offer post-operative monitoring. They are also more likely to invest in the next generation of technology.
   
• Further, the presence of skilled personnel, including a urologist, an anesthesiologist, and nursing staff, supports the effective use of complex equipment and patient management protocols.
   

Looking for region specific data?

Download Free PDF

North America dominated the global urology devices market with the highest market share of 42.5% in 2024.
 

• The U.S. market was valued at USD 11.9 billion and USD 12.7 billion in 2021 and 2022, respectively. In 2024, the market size increased to USD 14.4 billion from USD 13.5 billion in 2023. This growth is primarily attributed to the increased demand for minimally invasive procedures, technological advancements in urological diagnostics and therapeutics.
   

• North America benefits from a robust healthcare system, favorable reimbursement policies, and the presence of leading pharmaceutical and MedTech innovators such as Boston Scientific, Olympus, and Cook Medical. The region is also experiencing increased regulatory support from the FDA for innovative biologic delivery platforms.
   

The Europe urology devices market accounted for USD 9.9 billion in 2024.
 

• The growing prevalence of urological disorders is a major factor escalating market expansion across Europe. According to the European Association of Urology, these conditions are increasingly common among the region’s aging populations, contributing to the sustained demand for diagnostic and therapeutic urology devices.
   
• Moreover, Europe's favorable regulatory framework, particularly under the EU Medical Device Regulation (MDR), has reinforced safety and efficacy standards, building confidence among healthcare providers and patients and also the government backed healthcare reforms including funding for minimally invasive surgical tools and support for robotic assisted procedures are reinforcing growth potential of the urology device market in Europe.
   

Germany's urology device market is anticipated to witness considerable growth over the analysis period.
 

• Germany’s well-established network of urology departments in public and private hospitals, along with its leadership in surgical training and medical engineering, supports widespread adoption of endoscopic, laser, and robotic-assisted urology devices.
   
• The country is home to several internationally accredited urology centers that offer specialized treatments for kidney stones, prostate enlargement, and bladder disorders.
   

• The increasing incidence of age-related urological conditions, such as benign prostatic hyperplasia and urolithiasis, is significantly stimulating the use of minimally invasive urology devices. According to the Eurostat, 21.6% of Germany’s population was aged sixty-five and above as of 2024, a key factor contributing to the high urological disease burden and greater procedural volume.
   
• Moreover, Germany’s medical device market ranks among the largest in Europe, with strong domestic manufacturing capabilities strengthening its position in the market.
   

Asia Pacific urology devices market is anticipated to grow at the highest CAGR of 7.9% during the analysis time frame.
 

• The region is witnessing rapid growth due to rising awareness of urological health, a growing elderly population, and expansion of healthcare infrastructure, particularly in countries such as India, China, and Japan.
   
• These nations are experiencing a sharp increase in cases of urolithiasis, BPH, and urinary incontinence, thereby stimulating the adoption of diagnostic and minimally invasive surgical urology devices.
   
• Moreover, the number of urology clinics and surgical centers has surged across the region, and there is strong momentum towards equipping them with digital ureteroscopes, flexible endoscopes, and high-powered lithotripsy systems.
   
• The growing presence of global and regional manufacturers is also contributing to market expansion.
   

China urology devices market is predicted to grow significantly over the forecast period.
 

• The expanding elderly population is fuelling high demand for urology devices in China. The Chinese government's emphasis on improving access to specialty care through public hospital expansion and healthcare reforms is also contributing to the market growth.
   
• China had over two hundred million individuals aged 60 years and above in 2023, a demographic heavily associated with BPH and incontinence. Additionally, a nationwide increase in metabolic disorders and sedentary lifestyles is linked to a surge in kidney stone cases, further strengthening demand for ureteroscopes and related surgical tools.
   
• Moreover, the presence of a large number of local medical device manufacturers offering competitively priced products ranging from endoscopes to diagnostic imaging systems is helping improve device accessibility across primary and secondary care centers.
   

Brazil is experiencing significant growth in the Latin America urology devices market due to increased demand for advanced diagnostic tools.
 

• According to the Pan American Health Organization (PAHO), in 2022, Brazil had more than thirty million older adults aged 60 years and above, which represented 13% of the country’s population.
   
• This population group is particularly vulnerable to conditions such as BPH, kidney stones, which are fueling the market for advanced urology diagnostics and treatment.
   
• The country also leads the region in surgical procedure volumes, with a rising number of public and private hospitals performing urology-related interventions. Such a high clinical burden, coupled with expanding hospital infrastructure and specialist training programs, is anticipated to accelerate the adoption of devices.
• Demand is especially strong in urban centers where advanced robotic and laser technology are more readily available.
   

Saudi Arabia urology devices market is poised to witness substantial growth in the Middle East and Africa market during the forecast period.
 

• The growth was primarily stimulated by the country’s high burden associated with urological disorders and strategic investment in advanced surgical care under Vision 2030.
   
• The healthcare system is witnessing a shift towards minimally invasive and outpatient urology care, fueling demand for devices such as ureteroscopes and many others.
   
• Furthermore, the region is also attracting leading international urology companies while strengthening local capacity through training programs and infrastructure partnerships. This dual approach supports sustainable market growth and access to cutting-edge solutions.
   

Urology Devices Market Share

• Leading companies such as Boston Scientific, Olympus Corporation, Cook Medical, Siemens Healthineers, and Teleflex together hold an estimated 40% of the global market share. The market is moderately consolidated and driven by innovation in minimally invasive technologies, robotic surgical systems, diagnostic platforms, and chronic care solutions. These companies maintain their dominance through strong product portfolios, strategic acquisitions, regulatory approvals, and continuous R&D investment.
   
• Boston Scientific holds a competitive edge with its LithoVue single-use digital ureteroscope, widely adopted for kidney stone management and flexible ureteroscopy. Its focus on disposable technologies aligns with infection control protocols and cost-efficiency in hospital settings.
   
• Companies such as Teleflex are leveraging acquisitions to expand their urology portfolios, including solutions for bladder and prostate health. Their focus on biosimilar-compatible injectors and single-use devices supports broader market access and affordability. Players such as Laborie Medical Technologies address diagnostic gaps with advanced urodynamic testing systems, enabling precise evaluation of bladder function and pelvic floor disorders. Their tools are increasingly adopted in outpatient and specialty clinics.
   
• New entrants such as Ambu and BESDATA are disrupting the market with single-use cystoscopes, targeting infection control and cost-effective care in ambulatory settings. Their disposable solutions are gaining traction in high-volume clinical environments. Cook Medical and B. Braun continue to support procedural efficiency with a wide range of urological access and drainage products, including catheters and irrigation systems, reinforcing their presence in both surgical and chronic care segments.
   

Urology Devices Market Companies

A few of the prominent players operating in the urology devices industry include:

• Ambu
• B. Braun
• BESDATA
• Boston Scientific Corporation
• Coloplast
• Cook Medical
• Dornier MedTech
• HugeMed
• Intuitive Surgical
• Laborie Medical Technologies
• NIPRO
• Olympus Corporation
• Richard Wolf
• Siemens Healthineers
• Teleflex
   
• Olympus Corporation

Olympus stands out in the urology market with its VISERA ELITE III endoscopic visualization platform, which supports high-performance lithotripsy, BPH treatment, and soft tissue procedures. The company’s strategy centers on advanced imaging, energy systems, and infection prevention, offering a full suite of diagnostic and therapeutic tools for hospitals and outpatient clinics. Olympus’s commitment to patient safety, sustainability, and innovation for growth is reflected in its refreshed medical strategy, which aims to elevate standards of care in urology while expanding its presence in high-growth markets.
 

• Intuitive Surgical

Intuitive Surgical dominates the robotic-assisted urology segment with its Da Vinci Surgical System, widely used for prostatectomy, nephrectomy, and other complex procedures. Its latest innovations enable minimally invasive access with enhanced precision and reduced recovery times. Intuitive’s competitive advantage stems from its comprehensive ecosystem combining robotic platforms, digital insights, and surgeon training programs.
 

• Coloplast

Coloplast’s unique strength in the urology devices market lies in its patient-centric approach to continence care and catheter solutions. The company is widely recognized for its SpeediCath line of intermittent catheters, which are designed for ease of use, comfort, and reduced risk of urinary tract infections. Coloplast’s focus on chronic condition management, particularly for patients with spinal cord injuries, multiple sclerosis, and neurogenic bladder, positions it as one of the leaders in long-term urological care.
 

Urology Devices Industry News:

• In January 2024, the Boston Scientific Corporation entered into a definitive agreement to acquire Axonics, Inc., a medical technology company specializing in devices for urinary and bowel dysfunction. This acquisition marks Boston Scientific’s strategic expansion into the SNM therapy segment, a high-growth adjacency within urology. The move is expected to significantly strengthen Boston Scientific’s urology portfolio by adding differentiated technologies that address chronic pelvic health conditions.
   
• In April 2023, Medtronic and DaVita jointly launched Mozarc Medical, a new independent company focused on delivering innovative solutions for patients with kidney failure. Mozarc Medical combines the former Medtronic Renal Care Solutions (RCS) business with new talent and leadership to create a resolute kidney health technology company. Co-owned equally by Medtronic and DaVita, the venture aims to transform kidney care by developing home dialysis technologies, kidney access solutions, and acute therapy advancements. This strategic move allows both parent companies to leverage their expertise Medtronic’s in medical technology and DaVita’s in kidney care delivery to address growing global demand.
   

The urology devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Product
  • Endoscopes
    • Cystoscopes
      • Disposable
      • Reusable
    • Ureteroscopes
      • Disposable
      • Reusable
  • Laser and lithotripsy devices
  • Dialysis devices
  • Other products
• Accessories
  • Catheters
  • Stents
  • Lubricants and gels
  • Other accessories

Market, By Application

• Urolithiasis
• Urethral malignancies
• Bladder disorders
• Kidney diseases
• Erectile dysfunction
• Other applications

Market, By End Use

• Hospitals and clinics
• Dialysis centers
• Home care settings

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE